| Literature DB >> 23868198 |
Kazunobu Minakuchi1, Dai Murata, Yuji Okubo, Yoshiyuki Nakano, Shinichi Yoshida.
Abstract
Protein A affinity chromatography is the standard purification process for the capture of therapeutic antibodies. The individual IgG-binding domains of protein A (E, D, A, B, C) have highly homologous amino acid sequences. From a previous report, it has been assumed that the C domain has superior resistance to alkaline conditions compared to the other domains. We investigated several properties of the C domain as an IgG-Fc capture ligand. Based on cleavage site analysis of a recombinant protein A using a protein sequencer, the C domain was found to be the only domain to have neither of the potential alkaline cleavage sites. Circular dichroism (CD) analysis also indicated that the C domain has good physicochemical stability. Additionally, we evaluated the amino acid substitutions at the Gly-29 position of the C domain, as the Z domain (an artificial B domain) acquired alkaline resistance through a G29A mutation. The G29A mutation proved to increase the alkaline resistance of the C domain, based on BIACORE analysis, although the improvement was significantly smaller than that observed for the B domain. Interestingly, a number of other amino acid mutations at the same position increased alkaline resistance more than did the G29A mutation. This result supports the notion that even a single mutation on the originally alkali-stable C domain would improve its alkaline stability. An engineered protein A based on this C domain is expected to show remarkable performance as an affinity ligand for immunoglobulin.Entities:
Keywords: IgG-binding domain; affinity ligand; physicochemical stability; protein engineering; therapeutic antibody
Mesh:
Substances:
Year: 2013 PMID: 23868198 PMCID: PMC3776335 DOI: 10.1002/pro.2310
Source DB: PubMed Journal: Protein Sci ISSN: 0961-8368 Impact factor: 6.725